CDC confirms H5N1 bird flu infection in California child
Reportedly, the child experienced mild symptoms and has received flu antivirals.
What's going on with polio, monkeypox, and COVID-19
The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?
Antiviral treatment for hospitalized influenza pediatric patients declining
From 2017-2018, antiviral treatment of hospitalized children with influenza ranged from 70%-86%. In the 2023-2024 season, it was less than 60%.
Addressing atypical anorexia: Part 3
The final episode in our podcast series on atypical anorexia discusses fat bias in health care and its impact on diagnosis and when pushback against diagnosis happens.
Prenatally substance-exposed infants and SUID outcomes
Stephanie Anne Deutsch, MD, MS, MSCR, FAAP, joined us to discuss a new study that highlighted SUID among infants who were prenatally substance exposed.
FDA clears investigational NDA for VAX-31 to prevent invasive pneumococcal disease
The initiation of a phase 2 study of the investigational 31-valent pneumococcal conjugate vaccine is expected by the end of January 2025.
